What is Edwards Lifesciences's liability under transition services agreement?

Edwards Lifesciences (EW) reported liability under transition services agreement of $113.40M in Q1 2026.

How has Edwards Lifesciences's liability under transition services agreement changed year-over-year?

Edwards Lifesciences's liability under transition services agreement increased by 71.8% year-over-year, from $66.00M to $113.40M.

Other

Liability under transition services agreement

Edwards Lifesciences Liability under transition services agreement decreased by 8.1% to $113.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 71.8%, from $66.00M to $113.40M.

Analysis

StatementBalance Sheet Statement

SectionOther

First reportedQ4 2024

Last reportedQ1 2026

Metric ID: other_transition_services_agreement_liability_current

Historical Data

6 periods

	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$0.00	$66.00M	$60.30M	$84.40M	$123.40M	$113.40M
QoQ Change	—	—	-8.6%	+40.0%	+46.2%	-8.1%
YoY Change	—	—	—	—	—	+71.8%

Range$0.00 – $123.40M

Avg YoY Growth+71.8%

Median YoY Growth+71.8%

Frequently Asked Questions

What is Edwards Lifesciences's liability under transition services agreement?: Edwards Lifesciences (EW) reported liability under transition services agreement of $113.40M in Q1 2026.
How has Edwards Lifesciences's liability under transition services agreement changed year-over-year?: Edwards Lifesciences's liability under transition services agreement increased by 71.8% year-over-year, from $66.00M to $113.40M.